Cargando…
Patient‐derived preclinical models to develop immunotherapies
Cancer immunotherapy has revolutionized the treatment of some malignancies. Yet, many tumors do not unfortunately respond to immune‐based therapies. Deeper insights into the biology of the immune response to cancer are required to identify novel therapeutic targets and advance immuno‐oncology. To do...
| Autor principal: | |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
John Wiley and Sons Inc.
2023
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10323876/ https://www.ncbi.nlm.nih.gov/pubmed/37278114 http://dx.doi.org/10.1002/1878-0261.13470 |